← Back to headlines
BofA Raises Hims & Hers Target Amid FDA's Step Towards Wellness Peptides
Bank of America has increased its price target for Hims & Hers to $25, citing the FDA's recent move towards wellness peptides as a potential catalyst for a new revenue boom for the health company.
16 Apr, 14:34 — 16 Apr, 14:34
Sources
Showing 1 of 1 sources
